Chief Legal Compliance Officer, Corporate Secretary · Cue Biopharma, Inc. · Common Stock
Side
SELL
Value
$52K
Shares
1,844
Price
$28.05
Executed
Oct 12, 2026
Disclosed
Oct 14, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Oct 12 executedOct 14, 2026 disclosed
CUE · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Ray Sumita filed this Form 4 reporting a open-market sale of CUE on Oct 12, 2026. It became public on Oct 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
